ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
59.52
-0.04 (-0.07%)
Dec 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 59.27 - 60.03
52 week 50.77 - 70.90
Open 59.45
Vol / Avg. 729,240.00/1.06M
Mkt cap 8.38B
P/E 24.20
Div/yield 0.33/2.22
EPS 2.46
Shares 41.09M
Beta 0.88
Inst. own 225%
Jan 19, 2017
Q2 2017 ResMed Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 17, 2016
ResMed Inc Annual Shareholders Meeting (Estimated)
Nov 16, 2016
ResMed Inc Annual Shareholders Meeting
Oct 25, 2016
Q1 2017 ResMed Inc Earnings Call - Webcast
Oct 25, 2016
Q1 2017 ResMed Inc Earnings Release
Sep 13, 2016
ResMed Inc at Morgan Stanley Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin 16.35% 19.17%
Operating margin 20.23% 23.29%
EBITD margin - 28.43%
Return on average assets 9.28% 12.96%
Return on average equity 17.61% 21.47%
Employees 5,250 -
CDP Score - -

Address

9001 Spectrum Center Blvd
SAN DIEGO, CA 92123-1438
United States - Map
+1-858-7462400 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ResMed Inc. is a holding company. The Company, through its subsidiaries, designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. The Company develops a range of products for sleep-disordered breathing and other respiratory disorders, including airdevices, informatics solutions, diagnostic products, mask systems, headgear and other accessories. The Company owns interest in Inova Labs Inc., a medical device company specializing in the development and commercialization of oxygen therapy products. The Company holds interest in Brightree LLC, a provider of business management and clinical software applications for the post-acute care industry. The Company's manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Donald Darkin President – innovation & operations
Age: 62
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 52
Bio & Compensation  - Reuters
Anne Reiser President – Europe & Asia Pacific
Age: 54
Bio & Compensation  - Reuters
David Brian Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 57
Bio & Compensation  - Reuters
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 68
Bio & Compensation  - Reuters